Jung E. Choi
Net Worth

Last updated:

What is Jung E. Choi net worth?

The estimated net worth of Ms. Jung E. Choi is at least $16,705,344 as of 27 Sep 2022. She owns shares worth $9,319,914 as insider, has earned $814,230 from insider trading and has received compensation worth at least $6,571,200 in Global Blood Therapeutics, Inc..

What is the salary of Jung E. Choi?

Ms. Jung E. Choi salary is $657,120 per year as Chief Bus. & Strategy Officer in Global Blood Therapeutics, Inc..

How old is Jung E. Choi?

Ms. Jung E. Choi is 55 years old, born in 1970.

What stocks does Jung E. Choi currently own?

As insider, Ms. Jung E. Choi owns shares in one company:

Company Title Shares Price per share Total value
Global Blood Therapeutics, Inc. (GBT) Chief Bus. & Strategy Officer 136,077 $68.49 $9,319,914

What does Global Blood Therapeutics, Inc. do?

Global Blood Therapeutics, Inc., a biopharmaceutical company, engages in the discovery, development, and delivery of treatments for underserved patient communities with sickle cell disease (SCD). The company offers Oxbryta tablets, an oral, once-daily therapy for SCD. It also evaluates the safety and pharmacokinetics of single and multiple doses of Oxbryta in a Phase II a clinical trial of adolescent and pediatric patients with SCD. In addition, the company is developing its lead product candidate inclacumab, novel human monoclonal antibody, which is in Phase III a clinical trial to reduce the incidence of painful vaso-occlusive crises, and resulting hospital admissions; and GBT601, a hemoglobin polymerization inhibitor that is in Phase I development. It has a license and collaboration agreement with Syros Pharmaceuticals, Inc. to discover, develop, and commercialize therapies for SCD and beta thalassemia; and Sanofi S.A. to two early-stage research programs in SCD. Global Blood Therapeutics, Inc. was incorporated in 2011 and is headquartered in South San Francisco, California.

GBT logo
GBT
Global Blood Therapeutics, Inc.
$68.49

Jung E. Choi insider trading

Global Blood Therapeutics, Inc.

Ms. Jung E. Choi has made 11 insider trades between 2015-2022, according to the Form 4 filled with the SEC.

The largest trade she's ever made was exercising 74,964 units of GBT stock on 27 Sep 2022. As of 27 Sep 2022 she still owns at least 136,077 units of GBT stock.

Transaction Date Security Shares Price per share Total value Source
Option
Stock Option (Right to Buy) 16,902 $16.4 $277,193
Option
Common Stock 2,275 $65.82 $149,740
Option
Common Stock 16,902 $16.4 $277,193
Option
Stock Option (Right to Buy) 2,674 $3.4 $9,092
Option
Common Stock 2,674 $3.4 $9,092
Option
Stock Option (Right to Buy) 74,964 $3.4 $254,878
Option
Common Stock 2,674 $3.4 $9,092
Option
Common Stock 74,964 $3.4 $254,878
Option
Stock Option (Right to Buy) 2,275 $65.82 $149,740
Option
Common Stock 2,208 N/A N/A
Option
Restricted Stock Units 2,208 N/A N/A
Option
Restricted Stock Units 2,763 N/A N/A
Option
Common Stock 2,763 N/A N/A
Option
Restricted Stock Units 3,125 N/A N/A
Option
Restricted Stock Units 3,020 N/A N/A
Option
Common Stock 6,145 N/A N/A
Option
Restricted Stock Units 2,763 N/A N/A
Option
Common Stock 2,763 N/A N/A
Option
Common Stock 9,020 N/A N/A
Option
Restricted Stock Units 3,020 N/A N/A
Option
Restricted Stock Units 3,125 N/A N/A
Option
Restricted Stock Units 2,875 N/A N/A
Option
Restricted Stock Units 2,762 N/A N/A
Option
Common Stock 2,762 N/A N/A
Option
Common Stock 9,020 N/A N/A
Option
Restricted Stock Units 9,020 N/A N/A
Option
Restricted Stock Units 13,083 N/A N/A
Option
Common Stock 13,083 N/A N/A
Option
Restricted Stock Units 13,082 N/A N/A
Option
Common Stock 13,082 N/A N/A
Option
Common Stock 10,063 N/A N/A
Option
Restricted Stock Units 10,063 $21.94 $220,782
Option
Restricted Stock Units 10,063 $21.94 $220,782
Option
Common Stock 5,000 N/A N/A
Option
Restricted Stock Units 5,000 N/A N/A
Option
Restricted Stock Units 10,062 N/A N/A
Option
Restricted Stock Units 10,062 N/A N/A
Option
Common Stock 10,062 N/A N/A
Option
Restricted Stock Units 2,000 N/A N/A
Option
Common Stock 2,000 N/A N/A
Option
Common Stock 6,938 N/A N/A
Option
Restricted Stock Units 6,938 N/A N/A
Option
Common Stock 6,937 N/A N/A
Option
Restricted Stock Units 6,937 N/A N/A
Option
Restricted Stock Units 6,937 N/A N/A
Sale
Common Stock 1,600 $48.25 $77,200
Option
Common Stock 1,400 $3.4 $4,760
Option
Stock Option (Right to Buy) 799 $3.4 $2,717
Option
Stock Option (Right to Buy) 799 $3.4 $2,717
Sale
Common Stock 1,600 $45.5 $72,800
Option
Common Stock 1,400 $3.4 $4,760
Option
Common Stock 1,400 $3.4 $4,760
Option
Stock Option (Right to Buy) 799 $3.4 $2,717
Sale
Common Stock 1,600 $54.15 $86,640
Sale
Common Stock 1,600 $62.95 $100,720
Option
Stock Option (Right to Buy) 799 $3.4 $2,717
Option
Common Stock 1,400 $3.4 $4,760
Option
Restricted Stock Units 2,000 N/A N/A
Option
Common Stock 2,000 N/A N/A
Option
Common Stock 4,063 N/A N/A
Option
Restricted Stock Units 4,063 N/A N/A
Option
Common Stock 2,000 $59.6 $119,200
Option
Restricted Stock Units 2,000 $59.6 $119,200
Option
Common Stock 2,000 N/A N/A
Option
Restricted Stock Units 2,000 N/A N/A
Option
Employee Stock Option (Right to Buy) 799 $3.4 $2,717
Option
Common Stock 1,400 $3.4 $4,760
Sale
Common Stock 3,000 $52.85 $158,550
Option
Restricted Stock Units 2,000 $3.4 $6,800
Option
Common Stock 2,000 $3.4 $6,800
Option
Employee Stock Option (right to buy) 799 $3.4 $2,717
Option
Common Stock 1,400 $3.4 $4,760
Sale
Common Stock 1,600 $36.55 $58,480
Option
Employee Stock Option (right to buy) 799 $3.4 $2,717
Option
Common Stock 1,400 $3.4 $4,760
Sale
Common Stock 1,600 $39.75 $63,600
Option
Common Stock 1,400 $3.4 $4,760
Option
Employee Stock Option (right to buy) 799 $3.4 $2,717
Sale
Common Stock 1,600 $32.65 $52,240
Option
Common Stock 1,400 $3.4 $4,760
Sale
Common Stock 1,600 $30 $48,000
Option
Employee Stock Option (right to buy) 799 $3.4 $2,717
Option
Common Stock 1,400 $3.4 $4,760
Sale
Common Stock 1,600 $30 $48,000
Option
Employee Stock Option (right to buy) 799 $3.4 $2,717
Option
Restricted Stock Units 4,062 N/A N/A
Option
Common Stock 4,062 N/A N/A
Sale
Common Stock 1,600 $30 $48,000
Option
Employee Stock Option (right to buy) 799 $3.4 $2,717
Option
Common Stock 1,400 $3.4 $4,760
Purchase
Common Stock 50,000 $10 $500,000

Global Blood Therapeutics key executives

Global Blood Therapeutics, Inc. executives and other stock owners filed with the SEC: